AstraZeneca Quarterly Net Profit Rises 2% On Strong Cancer Drug Sales
Profit after tax climbed more than two percent to $2.5 billion in the three months to the end of June, compared with the same period last year, AstraZeneca said in a results statement. The post AstraZeneca Quarterly Net Profit Rises 2% On Strong Cancer Drug Sales appeared first o...
AI Summary
Profit after tax climbed more than two percent to $2.5 billion in the three months to the end of June, compared with the same period last year, AstraZeneca said in a results statement. The post AstraZeneca Quarterly Net Profit Rises 2% On Strong Cancer Drug Sales appeared first o...
AI-generated summary ·
Highlight any paragraph below to share it as a branded quote card
Full analysis is being generated — check back shortly.
Confirmed by Channels TV + others
🇳🇬 Channels TV
